Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Theresa Jakobsen"'
Autor:
Lasse S. Kristensen, Karoline K. Ebbesen, Martin Sokol, Theresa Jakobsen, Ulrik Korsgaard, Ann C. Eriksen, Thomas B. Hansen, Jørgen Kjems, Henrik Hager
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
The circular RNA named ciRS-7 is overexpressed in human cancers, however, its spatial cellular expression patterns have not been explored. Here, the authors show that ciRS-7 is not expressed in colon cancer cells, but abundant in stromal cells within
Externí odkaz:
https://doaj.org/article/1936aeae5ae645e7b1b908e2113e8300
Autor:
Agnete Marie Granau, Pilar Aarøe Andersen, Theresa Jakobsen, Konstantina Taouxi, Nawar Dalila, Johanne Bay Mogensen, Lasse Sommer Kristensen, Kirsten Grønbæk, Konstantinos Dimopoulos
Publikováno v:
Granau, A M, Andersen, P A, Jakobsen, T, Taouxi, K, Dalila, N, Mogensen, J B, Kristensen, L S, Grønbæk, K & Dimopoulos, K 2023, ' Concurrent Inhibition of Akt and ERK Using TIC-10 Can Overcome Venetoclax Resistance in Mantle Cell Lymphoma ', Cancers, vol. 15, no. 2, 510 . https://doi.org/10.3390/cancers15020510
Cancers; Volume 15; Issue 2; Pages: 510
Cancers; Volume 15; Issue 2; Pages: 510
Venetoclax, a BCL-2 inhibitor, has proven to be effective in several hematological malignancies, including mantle cell lymphoma (MCL). However, development of venetoclax resistance is inevitable and understanding its underlying molecular mechanisms c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7af08b9f21a0701674208bfcdbb5e50
https://curis.ku.dk/ws/files/335678235/cancers_15_00510_v4.pdf
https://curis.ku.dk/ws/files/335678235/cancers_15_00510_v4.pdf
Publikováno v:
Kristensen, L S, Jakobsen, T, Hager, H & Kjems, J 2022, ' The emerging roles of circRNAs in cancer and oncology ', Nature Reviews Clinical Oncology, vol. 19, pp. 188-206 . https://doi.org/10.1038/s41571-021-00585-y
Kristensen, L S, Jakobsen, T, Hager, H & Kjems, J 2022, ' The emerging roles of circRNAs in cancer and oncology ', Nature Reviews. Clinical Oncology, vol. 19, no. 3, pp. 188-206 . https://doi.org/10.1038/s41571-021-00585-y
Kristensen, L S, Jakobsen, T, Hager, H & Kjems, J 2022, ' The emerging roles of circRNAs in cancer and oncology ', Nature Reviews. Clinical Oncology, vol. 19, no. 3, pp. 188-206 . https://doi.org/10.1038/s41571-021-00585-y
Over the past decade, circular RNAs (circRNAs) have emerged as a large class of primarily non-coding RNA molecules, many of which have key roles in cancer development and progression through diverse mechanisms of action. CircRNAs often have tissue-re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97e2384fb5ec951ce47fc9136cab432f
https://portal.findresearcher.sdu.dk/da/publications/05ff886f-c390-4ce3-bef8-ab869930b98b
https://portal.findresearcher.sdu.dk/da/publications/05ff886f-c390-4ce3-bef8-ab869930b98b
Autor:
Lasse Sommer Kristensen, Mette Dahl, Theresa Jakobsen, Kirsten Grønbæk, Konstantinos Dimopoulos, Jørgen Kjems
Publikováno v:
Cancers, Vol 13, Iss 365, p 365 (2021)
Jakobsen, T, Dahl, M, Dimopoulos, K, Grønbæk, K, Kjems, J & Kristensen, L S 2021, ' Genome-wide circular rna expression patterns reflect resistance to immunomodulatory drugs in multiple myeloma cells ', Cancers, vol. 13, no. 3, 365, pp. 1-19 . https://doi.org/10.3390/cancers13030365
Cancers
Jakobsen, T, Dahl, M, Dimopoulos, K, Grønbæk, K, Kjems, J & Kristensen, L S 2021, ' Genome-wide circular RNA expression patterns reflect resistance to immunomodulatory drugs in multiple myeloma cells ', Cancers, vol. 13, no. 3, 365 . https://doi.org/10.3390/cancers13030365
Volume 13
Issue 3
Jakobsen, T, Dahl, M, Dimopoulos, K, Grønbæk, K, Kjems, J & Kristensen, L S 2021, ' Genome-wide circular rna expression patterns reflect resistance to immunomodulatory drugs in multiple myeloma cells ', Cancers, vol. 13, no. 3, 365, pp. 1-19 . https://doi.org/10.3390/cancers13030365
Cancers
Jakobsen, T, Dahl, M, Dimopoulos, K, Grønbæk, K, Kjems, J & Kristensen, L S 2021, ' Genome-wide circular RNA expression patterns reflect resistance to immunomodulatory drugs in multiple myeloma cells ', Cancers, vol. 13, no. 3, 365 . https://doi.org/10.3390/cancers13030365
Volume 13
Issue 3
Simple Summary Multiple myeloma (MM) constitutes the second most common hematological malignancy and is caused by aberrant plasma cell proliferation in the bone marrow. While recent improvements in the treatment of MM has been observed using immunomo